-
treatment option for
adults with
relapsing multiple sclerosis (brand name
Tecfidera). In 2017, an oral
formulation of
dimethyl fumarate (brand name Skilarence)...
- 1136/practneurol-2011-000092. PMID 22258169. S2CID 46326042. "Biogen Idec's
TECFIDERA™ (Dimethyl Fumarate)
Approved in US as a First-Line Oral
Treatment for...
-
erythroid 2(NF-E2)-related
factor 2)
transcription factor:
Dimethyl fumarate (
Tecfidera),
Diroximel fumarate (Vumerity),
approved by the FDA in
October 2019....
-
between 2009 and 2014 to
increase prescriptions of Avonex, Tysabri, and
Tecfidera (all for
multiple sclerosis).
Neurological diseases Kenneth Murray Eisai...
- stress. Two
precursors are also approved:
Dimethyl fumarate (brand name
Tecfidera),
Diroximel fumarate (brand name Vumerity),
approved by the FDA in October...
- hdl:2078.1/124907. PMID 21777829. S2CID 15639613. "Dimethyl
fumarate (
Tecfidera):
Fatal PML in an MS
patient with severe,
prolonged lymphopenia". "FDA...
-
common causes of PML. The
boxed warning had been
included for the
drugs Tecfidera and Gilenya, both of
which have had
incidences of PML
resulting in death...
- Betaseron/Betaferon
Bayer HealthCare 7 $876
million Dimethyl fumarate Tecfidera Biogen Idec 8 $303
million 4-Aminopyridine
Ampyra Acorda Therapeutics...
-
which is in the
public domain. "Key
Takeaways from Biogen's Q3 Call:
Tecfidera, Pipeline, Biosimilars". nasdaq.com. 27
October 2016.
Archived from the...
- Invega, Lunesta, Latisse, Entresto, Tremfya, Brineura, Privigen, Zykadia,
Tecfidera, Brukinsa, Zolgensma, Xpovio, and Qwo.
Brand Institute notably created...
